EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 183 filers reported holding EAGLE PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is 1.51 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $238,000 | -7.0% | 4,674 | +2.0% | 0.00% | -100.0% |
Q3 2021 | $256,000 | +5.3% | 4,584 | -19.4% | 0.00% | 0.0% |
Q2 2021 | $243,000 | +18.5% | 5,686 | +15.6% | 0.00% | 0.0% |
Q1 2021 | $205,000 | -2.8% | 4,918 | +8.4% | 0.00% | 0.0% |
Q4 2020 | $211,000 | -21.3% | 4,535 | +1.5% | 0.00% | 0.0% |
Q4 2019 | $268,000 | -5.0% | 4,468 | -10.5% | 0.00% | -50.0% |
Q3 2019 | $282,000 | -7.5% | 4,993 | -8.9% | 0.00% | 0.0% |
Q2 2019 | $305,000 | -2.2% | 5,478 | -11.3% | 0.00% | 0.0% |
Q1 2019 | $312,000 | +19.5% | 6,179 | -4.6% | 0.00% | 0.0% |
Q4 2018 | $261,000 | -51.2% | 6,477 | -16.0% | 0.00% | -50.0% |
Q3 2018 | $535,000 | -10.2% | 7,714 | -2.1% | 0.00% | 0.0% |
Q2 2018 | $596,000 | +38.6% | 7,878 | -3.4% | 0.00% | +33.3% |
Q1 2018 | $430,000 | -15.2% | 8,157 | -14.0% | 0.00% | -25.0% |
Q4 2017 | $507,000 | -8.3% | 9,486 | +2.3% | 0.00% | -20.0% |
Q3 2017 | $553,000 | -19.4% | 9,275 | +6.6% | 0.01% | -28.6% |
Q2 2017 | $686,000 | -12.5% | 8,698 | -7.9% | 0.01% | -12.5% |
Q1 2017 | $784,000 | -16.2% | 9,447 | -19.9% | 0.01% | -20.0% |
Q4 2016 | $936,000 | +22.7% | 11,795 | +8.3% | 0.01% | -9.1% |
Q3 2016 | $763,000 | +54.5% | 10,893 | -14.4% | 0.01% | +83.3% |
Q2 2016 | $494,000 | -3.3% | 12,723 | +0.8% | 0.01% | -14.3% |
Q1 2016 | $511,000 | -58.2% | 12,626 | -8.4% | 0.01% | -53.3% |
Q4 2015 | $1,222,000 | – | 13,786 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Hudson Executive Capital LP | 1,323,794 | $79,534,000 | 3.54% |
Park West Asset Management LLC | 1,171,880 | $70,406,000 | 2.96% |
Matarin Capital Management, LLC | 170,008 | $10,214,000 | 0.98% |
Smith, Graham & Co., Investment Advisors, LP | 140,014 | $8,412,000 | 0.82% |
Capital Impact Advisors, LLC | 33,725 | $2,026,000 | 0.71% |
U S GLOBAL INVESTORS INC | 18,800 | $1,130,000 | 0.51% |
CHARTWELL INVESTMENT PARTNERS, LLC | 187,989 | $11,294,000 | 0.37% |
Stanley-Laman Group, Ltd. | 24,000 | $1,442,000 | 0.34% |
GLOBEFLEX CAPITAL L P | 18,751 | $1,127,000 | 0.21% |
Foundry Partners, LLC | 70,357 | $4,227,000 | 0.16% |